CVSCVS HEALTH Corp

NYSE cvshealth.com


$ 58.33 $ 0.53 (0.92 %)    

Tuesday, 06-Aug-2024 15:59:58 EDT
QQQ $ 437.58 $ 4.16 (0.96 %)
DIA $ 389.72 $ 3.15 (0.81 %)
SPY $ 522.63 $ 4.77 (0.92 %)
TLT $ 96.88 $ -2.21 (-2.24 %)
GLD $ 220.73 $ -1.78 (-0.8 %)
$ 58.34
$ 58.29 x 100
$ 58.19 x 100
-- - --
$ 52.18 - $ 80.80
11,273,331
na
73.92B
$ 0.76
$ 10.10
TBD
na
na ($ 0.04)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 05-03-2023 03-31-2023 10-Q
6 02-08-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-09-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-18-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-14-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-02-2016 06-30-2016 10-Q
33 05-03-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 08-04-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 02-10-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Now Accessible To Over 116M Commercially Covered Lives; First FDA-Approved PCAB For GERD Treatment In Over 30 Years, Says Phath...

 walgreens-mulls-bond-sale-as-jpmorgan-gauges-investor-appetite-report

JP Morgan Chase is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance,...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-58-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $58 price target.

 is-big-pharma-poised-to-take-over-cannabis-3-companies-already-manage-8-in-10-drug-prescriptions-in-the-us

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on d...

Core News & Articles

The Federal Trade Commission is preparing to sue the largest three pharmacy-benefit managers over their tactics for negotiating...

 ftc-investigation-uncovers-anti-competitive-practices-by-handful-of-pharmacy-benefit-managers-including-cvs-health-unitedhealth

The FTC's report reveals how major PBMs like UnitedHealth, CVS, and Cigna influence drug prices, impacting small pharmacies...

 big-pharmacy-benefit-managers-increase-drug-costs-ftc-says---wall-street-journal

https://www.wsj.com/health/healthcare/big-pharmacy-benefit-managers-increase-drug-costs-ftc-says-c6a40ee6?mod=latest_headlines

 bitcoin-dip-not-over-yet-or-the-shorts-are-about-to-get-obliterated-says-ali-martinez

Bitcoin (CRYPTO: BTC) analyst Ali Martinez has recently shared insights on the current state of the cryptocurrency market, sugg...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION